These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3735530)

  • 1. Recurrences during the chemoprophylactic treatment of superficial tumors of the bladder.
    Ferraris V; Repetto E; Pisano PF; Albano D
    J Urol; 1986 Sep; 136(3):576-9. PubMed ID: 3735530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxorubicin plus mitomycin C regimen in the prophylactic treatment of superficial bladder tumors.
    Ferraris V
    Cancer; 1988 Sep; 62(6):1055-60. PubMed ID: 3136907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical mitomycin C instillation as a prophylactic treatment of superficial bladder tumor.
    Kim HH; Lee C
    J Urol; 1989 Jun; 141(6):1337-9; discussion 1339-40. PubMed ID: 2498532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant intravesical chemotherapy of superficial bladder cancer with monthly doxorubicin or intensive mitomycin. A comparison of two consecutive series.
    Ausfeld R; Beer M; Mühlethaler JP; Bartlome F; Widmer R; Tscholl R
    Eur Urol; 1987; 13(1-2):10-4. PubMed ID: 3582437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weekly mitomycin C followed by monthly bacillus Calmette-Guerin or alternating monthly interferon-alpha2B and bacillus Calmette-Guerin for prophylaxis of recurrent papillary superficial bladder carcinoma.
    Kaasinen E; Rintala E; Pere AK; Kallio J; Puolakka VM; Liukkonen T; Tuhkanen K
    J Urol; 2000 Jul; 164(1):47-52. PubMed ID: 10840422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A trial of prophylactic thiotepa or mitomycin C intravesical therapy in patients with recurrent or multiple superficial bladder cancers.
    Flanigan RC; Ellison MF; Butler KM; Gomella LG; McRoberts JW
    J Urol; 1986 Jul; 136(1):35-7. PubMed ID: 3086575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conservative treatment of high grade superficial bladder tumours.
    Trinchieri A; Bonacina P; Butti A; Cappoli S; Esposito N; Invernizzi S; Librizzi A; Locatelli G
    Arch Ital Urol Androl; 2005 Dec; 77(4):215-8. PubMed ID: 16444936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravesical combination chemotherapy with mitomycin C and doxorubicin for superficial bladder cancer: a randomized trial of maintenance versus no maintenance following a complete response.
    Fukui I; Kihara K; Sekine H; Tachibana Y; Kawai T; Ishiwata D; Oshima H
    Cancer Chemother Pharmacol; 1992; 30 Suppl():S37-40. PubMed ID: 1394814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravesical therapy of noninvasive bladder tumors (stage Ta) with doxorubicin: initial treatment results and the long-term course.
    Lundbeck F; Bruun E; Finnerup B; Christophersen IS
    J Urol; 1988 Jun; 139(6):1212-3. PubMed ID: 3373590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of patients with frequently recurrent non-muscle-invasive bladder carcinoma treated with one perioperative plus four weekly instillations of mitomycin C followed by monthly bacillus Calmette-Guérin (BCG) or alternating BCG and interferon-α2b instillations: prospective randomised FinnBladder-4 study.
    Järvinen R; Marttila T; Kaasinen E; Rintala E; Aaltomaa S; Kallio J; Liukkonen T; Puolakka VM; Seppänen M; Tuhkanen K; Vaarala M; Viitanen J; Boström PJ;
    Eur Urol; 2015 Oct; 68(4):611-7. PubMed ID: 25748117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy in bladder cancer with keyhole-limpet hemocyanin: a randomized study.
    Jurincic CD; Engelmann U; Gasch J; Klippel KF
    J Urol; 1988 Apr; 139(4):723-6. PubMed ID: 3127600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of different schedules of cytostatic intravesical instillations in patients with superficial bladder carcinoma: final evaluation of a prospective multicenter study with 419 patients.
    Huland H; Klöppel G; Feddersen I; Otto U; Brachmann W; Hubmann H; Kaufmann J; Knipper W; Lantzius-Beninga F; Huland E
    J Urol; 1990 Jul; 144(1):68-71; discussion 71-2. PubMed ID: 2113590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravesical chemotherapy for carcinoma in situ of the urinary bladder: 5 years later.
    Jakse G
    Eur Urol; 1984; 10(5):289-93. PubMed ID: 6440791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expectant management of small, recurrent, noninvasive papillary bladder tumors.
    Soloway MS; Bruck DS; Kim SS
    J Urol; 2003 Aug; 170(2 Pt 1):438-41. PubMed ID: 12853794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of valrubicin for the treatment of Bacillus Calmette-Guerin refractory carcinoma in situ of the bladder. The Valrubicin Study Group.
    Steinberg G; Bahnson R; Brosman S; Middleton R; Wajsman Z; Wehle M
    J Urol; 2000 Mar; 163(3):761-7. PubMed ID: 10687972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostatic recurrences in the management of superficial bladder tumors.
    Lockhart JL; Chaikin L; Bondhus MJ; Politano VA
    J Urol; 1983 Aug; 130(2):256-7. PubMed ID: 6410083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superficial bladder cancer.
    Trybula M; King M
    Med Pediatr Oncol; 1985; 13(6):384-9. PubMed ID: 2413339
    [No Abstract]   [Full Text] [Related]  

  • 18. Histological grading of carcinoma in situ of the bladder: its clinical significance in patients who underwent intravesical mitomycin C and doxorubicin sequential therapy.
    Sekine H; Fukui I; Yamada T; Yamada T; Kojima S; Ohshima H
    J Urol; 1996 Jan; 155(1):94-8; discussion 98-9. PubMed ID: 7490908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of a randomized, double blind prospective study of intravesical chemoprophylaxis with 2 drugs: adriamycin and mitomycin; and 2 ways of initiating the instillations: early and late. Effect on recurrence and progression].
    Iborra Juan I; Ricos Torrent JV; Monrós Lliso JL; Dumont Martínez R; Casanova Ramón-Borja J; Solsona Narbón E
    Arch Esp Urol; 1992 Dec; 45(10):1001-7. PubMed ID: 1294028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mitomycin C in the topical treatment of superficial neoplasms of the bladder].
    Milani C; Bassi PF; Meneghini A; Giunta A; Tejerizo JC; dal Bianco M; Zattoni F; Garbeglio A
    Arch Esp Urol; 1989 Oct; 42(8):761-7. PubMed ID: 2515812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.